文献速递心脑血管急症重症综合管理与镇静镇痛

乳酸与白蛋白比值及胆固醇水平预测心脏骤停存活者神经功能结局

Lactate-to-albumin ratio and cholesterol levels predict neurological outcome in cardiac arrest survivors.
PubMed 文献 · Am J Emerg Med · 2024-06-25
一句话结论院外心脏骤停存活者复苏后6小时乳酸/白蛋白比值<3.7 mmol/dag、白蛋白>3.1 g/dL、总胆固醇>146.4 mg/dL、HDL胆固醇>31.9 mg/dL提示神经功能预后良好。

这项回顾性观察研究纳入2015年1月至2023年6月ICU收治的219例院外心脏骤停存活者,按脑功能分类(CPC)评分分为预后良好组(CPC 1–2分,A组)和预后不良组(CPC 3–5分,B组),分析复苏后6小时乳酸、白蛋白及血脂谱。约40%患者30天随访时神经功能预后良好。A组乳酸/白蛋白比值显著低于B组(3.1 vs 5.0 mmol/dag,p<0.001),白蛋白、总胆固醇和HDL胆固醇显著高于B组(分别为3.6 vs 2.9 g/dL、166.1 vs 131.4 mg/dL、38.8 vs 29.7 mg/dL,p<0.001)。作者认为入院时上述指标可预测神经功能预后,建议复苏后6小时常规检测,尤其乳酸>5 mmol/L者。

要点

  • A组乳酸/白蛋白比值显著低于B组(3.1 vs 5.0 mmol/dag,p<0.001),提示比值越低神经功能预后越好。
  • A组白蛋白、总胆固醇、HDL胆固醇均显著高于B组(3.6 vs 2.9 g/dL、166.1 vs 131.4 mg/dL、38.8 vs 29.7 mg/dL,p<0.001)。
  • 预后良好阈值:乳酸/白蛋白比值<3.7 mmol/dag、白蛋白>3.1 g/dL、总胆固醇>146.4 mg/dL、HDL胆固醇>31.9 mg/dL。
  • 乳酸/白蛋白比值、白蛋白、总胆固醇、HDL胆固醇的AUC分别为0.70、0.75、0.71、0.71,对应OR分别为3.37、7.08、3.67、3.94。
  • 作者建议复苏后6小时常规检测这些生物标志物,尤其乳酸>5 mmol/L的患者。

适用人群与场景

  • 2015年1月至2023年6月ICU收治的219例院外心脏骤停(OHCA)存活者。
  • 按脑功能分类(CPC)评分分组:A组CPC 1–2分(神经功能预后良好),B组CPC 3–5分(神经功能预后不良)。

诊断标准与关键阈值

  • 神经功能预后良好阈值:乳酸/白蛋白比值<3.7 mmol/dag、白蛋白>3.1 g/dL、总胆固醇>146.4 mg/dL、HDL胆固醇>31.9 mg/dL。

处置流程与药物剂量

  • 复苏后6小时测量乳酸、白蛋白及血脂谱(总胆固醇、HDL胆固醇),尤其乳酸>5 mmol/L的患者(作者建议)。

研究设计与关键结果

  • 回顾性观察研究,纳入219例OHCA存活者,约40%患者30天随访时神经功能预后良好。
  • A组乳酸/白蛋白比值显著低于B组(3.1 vs 5.0 mmol/dag,p<0.001)。
  • A组白蛋白显著高于B组(3.6 vs 2.9 g/dL,p<0.001)。
  • A组总胆固醇显著高于B组(166.1 vs 131.4 mg/dL,p<0.001)。
  • A组HDL胆固醇显著高于B组(38.8 vs 29.7 mg/dL,p<0.001)。
  • 乳酸/白蛋白比值、白蛋白、总胆固醇、HDL胆固醇的AUC分别为0.70、0.75、0.71、0.71,OR分别为3.37、7.08、3.67、3.94。
  • 上述生物标志物具有高敏感性和阴性预测值。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为入院时乳酸/白蛋白比值、白蛋白、总胆固醇和HDL胆固醇水平可预测OHCA存活者的神经功能预后。
  • 作者建议常规 practice 应包括复苏后6小时测量这些生物标志物,尤其乳酸>5 mmol/L的患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Out-of-hospital cardiac arrest (OHCA) increases lactate levels and reduces albumin levels on admission and tends to lead to a poor neurological prognosis. In our experience, reduced cholesterol levels predict poor neurological prognosis. However, the relationship between cholesterol levels and neurological prognosis in OHCA survivors remains unclear.

METHODS: This retrospective observational study included data from January 2015 to June 2023 on 219 OHCA survivors at our intensive care unit. Patients were categorized into two groups based on cerebral functional classification (CPC) scores: Group A (CPC score of 1 or 2), including patients with a favorable neurological outcome, and Group B (CPC scores of 3 to 5), comprising those with a poor neurological outcome. We analyzed their lactate, albumin levels, and lipid profiles measured at 6 h after resuscitation. A model to predict the neurological prognosis of admission of OHCA survivors was developed.

RESULTS: Approximately 40% of the patients had favorable neurological outcomes at the 30-day follow-up. The lactate-to-albumin ratio (LAR) was significantly lower in Group A than in Group B (3.1 vs. 5.0 mmol/dag, p < 0.001). However, the albumin, total cholesterol, and high-density lipoprotein (HDL) cholesterol levels were significantly higher in Group A than in Group B (3.6 vs. 2.9 g/dL, 166.1 vs. 131.4 mg/dL, and 38.8 vs. 29.7 mg/dL, respectively, p < 0.001). Favorable neurological outcome was indicated at the following thresholds: LAR < 3.7 mmol/dag, albumin level > 3.1 g/dL, total cholesterol level > 146.4 mg/dL, and HDL-cholesterol level > 31.9 mg/dL. These findings underscore the high sensitivity and negative predictive value of the biomarkers. Furthermore, the area under the curve values for LAR, albumin, total cholesterol, and HDL-cholesterol levels were 0.70, 0.75, 0.71, and 0.71, respectively. The corresponding odds ratios were 3.37, 7.08, 3.67, and 3.94, respectively.

CONCLUSIONS: The LAR, albumin, total cholesterol, and HDL-cholesterol levels measured on admission may predict neurological prognosis in OHCA survivors. Thus, routine practice should include the measurement of these biomarkers at 6 h after resuscitation, especially in patients with a lactate level of > 5 mmol/L.

TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT02633358.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Chen DL, Chung CM, Wang GJ, et al. Lactate-to-albumin ratio and cholesterol levels predict neurological outcome in cardiac arrest survivors. Am J Emerg Med. 2024. PMID: 38943710. doi:10.1016/j.ajem.2024.06.029

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。